Testing kidney reserve after a protein load
Part of Kidney & urinary clinical trials.
This study looks at how well your kidneys respond to a protein 'challenge' (a special drink or meal) by measuring what is called 'renal reserve.' It may help doctors better understand kidney function and could be useful for monitoring kidney health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be over 18 years old
- Your kidney function should be moderately good (eGFR above 30)
- You must be able to fast (not eat) for at least 8 hours before the test day
- If you are female and can get pregnant, you need a negative pregnancy test and agree to use birth control during the study
- You cannot be taking certain blood pressure or diabetes medications (like ACE inhibitors, ARBs, or SGLT2 inhibitors) that you cannot pause for the study
- You should not have skin problems on your chest (like significant scarring, tattoos, or pigmentation changes) that could affect the sensor readings
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a sensor placed on the skin to measure kidney function in adults with heart failure. It may help understand how well the kidneys are working without repeated blood draws.
This study looks at how different levels of kidney function affect the amount of a medication in the body. It may help doctors decide on the right dose for people with kidney problems.
This study looks at how the kidneys work in both healthy people and those with reduced kidney function. Researchers want to understand kidney health better to help people in the future.
This trial tests if a new drug, R3R01, can help reduce protein leaking into the urine in people with diabetic kidney disease. It may offer a new option for managing kidney health.
This study compares two experimental treatments—one that reduces protein in urine and another that may help control blood sugar and weight—for people with chronic kidney disease. It aims to find safer, more effective ways to slow kidney damage.
This study tests a single dose of an investigational medicine (NNC0537-1482) to see how it moves through the body in people with different levels of kidney function. It may help researchers understand how the drug is processed so it can be dosed safely in future studies.
Hear when a new Glomerular Filtration Rate trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.